Today in News History

On July 13, several notable moments in the history of News stand out. In 1892, Léo-Pol Morin, Canadian pianist, composer, and educator (died 1941) was born. In 1960, Ian Hislop, Welsh-English journalist and screenwriter was born. In 1965, Akina Nakamori, Japanese singer and actress was born. In 1970, Sheng Shicai, Chinese warlord (born 1895) passed away. In 1975, Mariada Pieridi, Cypriot singer-songwriter was born. In 1979, Daniel Díaz, Argentinian footballer was born. In 1979, Libuše Průšová, Czech tennis player was born. In 1980, Seretse Khama, Botswana lawyer and politician, 1st President of Botswana (born 1921) passed away. In 1982, Shin-Soo Choo, South Korean baseball player was born. In 2003, French DGSE personnel abort an operation to rescue Íngrid Betancourt from FARC rebels in Colombia, causing a political scandal when details are leaked to the press. Together, these milestones provide historical context for today's news news and ongoing narratives.

Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug

Bloomberg

Bloomberg

·

July 10, 2026

·

lean left

Apnimed Inc. filed for a US initial public offering, as its oral drug to treat obstructive sleep apnea moves closer to being commercialized.

Narrative Intelligence Brief

This article was published by Bloomberg, a source frequently categorized with a lean left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Bloomberg, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 28 related reports from 28 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

28 sources

Left 32%

Center 43%

Right 21%


Global News

center

· Jun 24, 2026

Health Canada approves drug that treats sleep apnea in adults with obesity

Zepbound the now the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked.

MyJoyOnline

center

· Jun 22, 2026

Ashanti Health Directorate fights Neglected Tropical Diseases with distribution of free medications

The Ashanti Regional Health Directorate has launched a mass drug administration campaign targeted at eliminating river blindness and bilharziasis across nine endemic districts in the region. The endemic districts have been identified as Ahafo North, Asante Mampong, Atwima Mponua, Offinso North, and Ejura Sekyeredumase. Others are the Sekyere East and Central districts, Sekyere Kumawu, and []

CityNews Montreal

center

· Jun 24, 2026

Health Canada approves weight-loss drug for sleep apnea in patients with obesity

Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity. The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked. That blockage can [] The post Health Canada approves weight-loss drug for sleep apnea in patients with obesity appeared first on CityNews Montreal.

Investing.com

center

· Jul 6, 2026

Form 4 Ionis Pharmaceuticals Inc For: 6 July

Form 4 Ionis Pharmaceuticals Inc For: 6 July

Voice of Nigeria

lean right

· Jun 29, 2026

FDA Reviews Sandoz Generic Obesity Drug Applications

The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.

The Epoch Times

right

· Jul 8, 2026

RFK Jr. Announces $281 Million for Addiction Treatment, Mental Health Programs

The funding includes 68.2 million to expand medication-assisted treatment for opioid use disorder.

Drudge Retort

left

· Jun 26, 2026

One 79-year-old Patient Given Unapproved Powerful Obesity Drug

Speculation swirled around a report that a single patient -- a 79-year-old man -- was given access to a powerful new obesity drug that's still awaiting federal approval.

The Hindu BusinessLine

lean right

· Jun 29, 2026

Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel

The approval by the USFDA is for the abbreviated new drug application (ANDA) of Dapsone gel, 5 per cent

Foreign Policy Journal

left

· Jul 1, 2026

Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs

Medicare is launching a temporary bridge program that will cover select GLP-1 weight-loss medications from two of the pharmaceutical industry’s largest players. The program will extend coverage to Novo Nordisk’s (CPH: NOVO-B) Wegovy, both in injection and tablet form, marking a significant shift in how the federal health program approaches obesity treatment. Eli Lilly’s (NYSE: [] The post Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs appeared first on Foreign Policy Journal.

Seeking Alpha

lean right

· Jun 25, 2026

Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction - Slideshow

Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction - Slideshow

Vanguard News

lean left

· Jul 6, 2026

Onitsha Medicine Market hands over fake, expired drugs worth N430m to NAFDAC

By Chimaobi Nwaiwu NNEWI — The leadership of the Ogbo Ogwu Medicine Market in Onitsha, Anambra State, has handed over fake, expired and other unwholesome drugs valued at more than N430 million to the National Agency for Food and Drug Administration and Control (NAFDAC) for destruction, as part of efforts to rid the market of [] The post Onitsha Medicine Market hands over fake, expired drugs worth N430m to NAFDAC appeared first on Vanguard News.

Ariana News

lean right

· Jun 21, 2026

Afghanistan intensifies fight against synthetic drugs

Officials described synthetic drugs as one of the country's most pressing concerns and said targeted programs have been introduced to combat the problem. The post Afghanistan intensifies fight against synthetic drugs first appeared on Ariana News | Afghanistan News.

Medical Daily

center

· Jun 30, 2026

A New Vaccine Option Is Now Available for Kids with Diabetes, Heart Disease, or Other Chronic Conditions

FDA approved Capvaxive for kids 2-17 with chronic conditions like diabetes and heart disease, June 18, 2026. Here's what families managing pediatric chronic illness need to know.

Dateline Nigeria

center

· Jul 8, 2026

FG committed to dismantling drug cartels – SGF Akume

– Substance use summit convened to mobilise National Action Plan against drug scourge, says Marwa – UNODC, Health Ministry seek translation of commitment into practical, measurable action The Federal Government has reaffirmed its commitment to every initiative aimed at preventing illicit drug use, dismantling trafficking networks, expanding access to treatment and rehabilitation, and promoting The post FG committed to dismantling drug cartels – SGF Akume appeared first on Dateline Nigeria.

Ghanaian Times

center

· Jul 9, 2026

Newmont supports University of Ghana Health Services

Newmont has supported the University of Ghana Health Services at Legon with a donation of essential medical equipment valued at over GH¢ 290,000, reinforcing its commitment to safety and strengthening healthcare delivery in Ghana. The equipment was donated following a request from the Internal Medicine Department of the facility, which provides care to a large The post Newmont supports University of Ghana Health Services appeared first on Ghanaian Times.

The Economic Times

lean right

· Jul 12, 2026

EPFO rolls out one-time PF trust amnesty

EPFO rolls out one-time PF trust amnesty

BizNews

center

· Jul 12, 2026

Marika Sboros: Inside SA’s Ozempic copycat case exposing “Fat Drug” free-for-all

Marika Sboros: Inside SA’s Ozempic copycat case exposing “Fat Drug” free-for-all

Middle East News 247

center

· Jul 6, 2026

Al Jafiliya Immigration Office 2026: Visa, Emirates ID & Complete Guide

If you need reliable help with visas, permits, or residency-related matters, this guide explains why the Al Jafiliya Immigration Office is one of the most trusted government service centers in the UAE. Operated by the General Directorate of Residency and Foreigners Affairs (GDRFA) and GDRFA Dubai, this authorised government entity works as the primary government [] The post Al Jafiliya Immigration Office 2026: Visa, Emirates ID Complete Guide appeared first on Middle East News 247.

The Next Web

lean left

· Jul 6, 2026

Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US

Your prescription, printed to order. A Finnish startup wants to turn the back room of your pharmacy into a tiny, automated drug factory, and it just raised 14m to do it in America. CurifyLabs has closed a 14m (12m) Series A, the company announced. The Helsinki firm makes machines and software that let pharmacies 3D-print [] This story continues at The Next Web

Fortune

center

· Jun 21, 2026

A better sunscreen has been available in Europe for 25 years. It just became legal to sell in the U.S.

Bemotrizinol — already common in Mexico, Canada and South Korea — won FDA approval on June 9, ending a 27-year freeze on new OTC sunscreen ingredients.

Economic Times

center

· Jul 6, 2026

Rentomojo gets Sebi's approval to float IPO

Rentomojo, an innovative online rental platform specializing in furniture and appliances, has received approval from Sebi for its Initial Public Offering (IPO). Aiming to raise up to Rs 150 crore through new equity and an Offer for Sale by current shareholders, the proceeds will support loan repayments, warehouse rentals, and overall business operations. With a strong subscriber base and diverse product offerings in various cities, Rentomojo is poised for growth.

The Tico Times

center

· Jul 4, 2026

Costa Rican Travelers Get New Global eSIM Option

Costa Rican telecommunications brand kölbi has launched a new Global eSIM service with Airalo, giving travelers a way to buy international data packages before leaving the country and connect abroad without changing their physical SIM card. The service, called kölbi eSIM Global by Airalo, was announced by the Instituto Costarricense de Electricidad, (ICE) which operates [] The post Costa Rican Travelers Get New Global eSIM Option appeared first on The Tico Times | Costa Rica News | Travel | Real Estate.

Kaiser Health

lean left

· Jun 25, 2026

Opioid Settlement Money Pays for Services To Battle Addiction in Rural Kentucky

A program in rural eastern Kentucky is receiving opioid settlement funding to address substance use disorders, housing, hunger, and other challenges.

Vogue

left

· Jul 9, 2026

Why Everyone’s Turning to Minoxidil for Hair Growth

The sole FDA-approved over-the-counter ingredient for hair growth, minoxidil stands out for its time-tested, science-backed ability to help stymie hair loss and support hair growth.

AllAfrica

lean left

· Jul 10, 2026

Kenya: Ombudsman Orders Release of NHIF, SHA Hospital Payment Records Within 21 Days

[Capital FM] Nairobi -- The Commission on Administrative Justice (CAJ) has ordered the release of detailed records of payments made to hospitals under the defunct National Hospital Insurance Fund (NHIF) and the Social Health Authority (SHA), citing the constitutional right of access to information.

Quartz

lean left

· Jun 29, 2026

Medicare is starting to cover weight loss drugs for some seniors. Here's what to know

The drugs covered under the program include Wegovy tablets and injections, Zepbound KwikPens, and Foundayo tablets

Sweden Herald

Unknown

· Jun 26, 2026

UN Report: Huge Increase in Synthetic Drugs Worldwide

UN Report: Huge Increase in Synthetic Drugs Worldwide

The Motley Fool

lean left

· Jul 5, 2026

Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors?

Septerna, a clinical-stage biotech focused on GPCR-targeted therapies, reported significant insider selling in its latest SEC filing.

Topics:

World · 11
Business · 8
Politics · 4
Health · 2
Unknown · 1

Related coverage for "Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug": Global News — Health Canada approves drug that treats sleep apnea in adults with obesity. MyJoyOnline — Ashanti Health Directorate fights Neglected Tropical Diseases with distribution of free medications. CityNews Montreal — Health Canada approves weight-loss drug for sleep apnea in patients with obesity. Investing.com — Form 4 Ionis Pharmaceuticals Inc For: 6 July. Voice of Nigeria — FDA Reviews Sandoz Generic Obesity Drug Applications. The Epoch Times — RFK Jr. Announces $281 Million for Addiction Treatment, Mental Health Programs. Drudge Retort — One 79-year-old Patient Given Unapproved Powerful Obesity Drug. The Hindu BusinessLine — Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel. Foreign Policy Journal — Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs. Seeking Alpha — Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction - Slideshow. Vanguard News — Onitsha Medicine Market hands over fake, expired drugs worth N430m to NAFDAC. Ariana News — Afghanistan intensifies fight against synthetic drugs. Medical Daily — A New Vaccine Option Is Now Available for Kids with Diabetes, Heart Disease, or Other Chronic Conditions. Dateline Nigeria — FG committed to dismantling drug cartels – SGF Akume. Ghanaian Times — Newmont supports University of Ghana Health Services. The Economic Times — EPFO rolls out one-time PF trust amnesty . BizNews — Marika Sboros: Inside SA’s Ozempic copycat case exposing “Fat Drug” free-for-all. Middle East News 247 — Al Jafiliya Immigration Office 2026: Visa, Emirates ID & Complete Guide. The Next Web — Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US. Fortune — A better sunscreen has been available in Europe for 25 years. It just became legal to sell in the U.S.. Economic Times — Rentomojo gets Sebi's approval to float IPO . The Tico Times — Costa Rican Travelers Get New Global eSIM Option. Kaiser Health — Opioid Settlement Money Pays for Services To Battle Addiction in Rural Kentucky. Vogue — Why Everyone’s Turning to Minoxidil for Hair Growth. AllAfrica — Kenya: Ombudsman Orders Release of NHIF, SHA Hospital Payment Records Within 21 Days. Quartz — Medicare is starting to cover weight loss drugs for some seniors. Here's what to know. Sweden Herald — UN Report: Huge Increase in Synthetic Drugs Worldwide. The Motley Fool — Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors?